API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/bioarctic-receives-meur-15-milestone-payment-from-eisai-for-start-of-ban2401-confirmatory-phase-3-study-in-early-alzheimers-disease-300853227.html
https://www.prnewswire.com/news-releases/bioarctic-eisai-announces-timelines-for-the-single-confirmatory-phase-3-study-with-ban2401-in-warly-alzheimers-disease-300808348.html
http://www.pmlive.com/pharma_news/biogen,_eisai_cue_up_ban2401_readout_in_alzheimers_in_2022_1280698